In T-cell acute lymphoblastic leukemia (T-ALL) cancer cells and during thymocyte differentiation in vivo, distinct patterns of alternative splicing are associated with BRD4 deletion (Uppal et al., 2019). The gene discussed is BRD4; the disease is cancer.